EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of the kappa-opioid receptor agonist U-50,488H upon kainic acid-induced alterations in glucose utilization in the rat hippocampus



The effect of the kappa-opioid receptor agonist U-50,488H upon kainic acid-induced alterations in glucose utilization in the rat hippocampus



British Journal of Pharmacology 114(PROC SUPPL ): 138P




(PDF emailed within 1 workday: $29.90)

Accession: 033785623

Download citation: RISBibTeXText



Related references

The interaction between kappa-opioid agonist, U-50, 488H, and kainic acid: behavioral and histological assessments. Brain Research 482(2): 333-339, 1989

Effect of chronic administration of naltrexone on brain mu- and kappa-opioid receptors and responses to U-50,488H, a kappa-opioid receptor agonist in the mouse. FASEB Journal 9(3): A102, 1995

Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse. Brain Research 649(1-2): 111-116, 1994

U-50,488H, a selective kappa opioid receptor agonist, ameliorates memory impairments induced by muscarinic autoreceptor agonist, carbachol in mice. Neuroscience Letters 236(1): 45-48, 1997

The effect of mu and kappa opioid receptor agonists on cAMP level in hippocampus of kainic acid-treated rats. Polish Journal of Pharmacology 47(2): 121-126, 1995

Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat. Pharmacology 39(3): 145-153, 1989

Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat. European Journal of Pharmacology 235(1): 23-30, 1993

U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice. Brain Research 619(1-2): 223-228, 1993

The effect of kappa-opioid agonist U-50, 488H on wet-dog shaking behavior induced by hippocampal stimulation in rats. Psychopharmacology 91(2): 189-192, 1987

The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats. Journal of Pharmacology and Experimental Therapeutics 264(2): 631-637, 1993

The effects of the kappa opioid receptor agonist u 50488h on kainic acid neurotoxicity. Society for Neuroscience Abstracts 13(2): 1306, 1987

Mu Opioid induced respiratory depression antagonized by kappa opioid agonist MR-2034 but not by U-50, 488H in freely moving rats. Regulatory Peptides 54(1): 215-216, 1994

Effects of U-50,488H on isolated atria from rats chronically treated with the kappa-opioid agonist, U-50,488H. Journal of Autonomic Pharmacology 18(6): 371-375, 1999

Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H. Alcohol 43(5): 359-365, 2009

Studies on drug dependence Effects of a selective kappa-opioid agonist, U-50, 488H, an delta-opioid agonists-induced place preference. Japanese Journal of Pharmacology 64(SUPPL 1): 221P, 1994